Latest filing published 04 Sept 2026 for Tarsus Pharmaceuticals, Inc., €811k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lin Elizabeth Yeu: trading record in brief
All filings by Lin Elizabeth Yeu on record concern Tarsus Pharmaceuticals, Inc. Altogether 2 filings, all relating to 4 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 4 September 2026, the filings show a transaction worth €811k in Tarsus Pharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lin Elizabeth Yeu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,773 shares@ US$87.4998CommonSEC144:0001959173-26-006758
- 3,180 shares@ US$87.50CommonSEC144:0001959173-26-006760
2 of 2 declarations
